About Us

Who We Are:

The Metabolic Signalling Lab is at the forefront of research into cancer biology and metabolic regulation.

Under the leadership of Professor Marco Falasca, our team investigates the intricate cellular processes driving diseases such as pancreatic cancer and type 2 diabetes, with a focus on developing targeted, more effective therapies.

Our Vision

Empowering Health

We believe that understanding the molecular language of cells is the key to defeating some of the world’s most challenging diseases. By combining fundamental science with translational research, our goal is to deliver innovative therapies that can transform patient outcomes.

Team

Meet Our Experts

Prof. Marco Falasca

Team Leader

Professor Marco Falasca is an internationally recognised scientist with more than 30 years of research experience in leading institutions including New York University, University College London, and Queen Mary University of London. Now based at the University of Parma, his pioneering discoveries in cancer biology and metabolic signalling have influenced global research and therapeutic development.

Key Achievements:

Discovery of potential cannabis-based treatments for pancreatic cancer.
Identification of novel molecular targets in pancreatic ductal adenocarcinoma (PDAC).
Groundbreaking work on the role of lipid signalling and gastrointestinal hormones in metabolic diseases.
Extensive collaboration with pharmaceutical companies to bring lab findings to clinical trials.